- Home
- IGA vs RPTX Comparison
IGA vs RPTX Comparison
Compare IGA & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGA
- RPTX
- Stock Information
- Founded
- IGA 2005
- RPTX 2016
- Country
- IGA United States
- RPTX Canada
- Employees
- IGA N/A
- RPTX N/A
- Industry
- IGA Investment Managers
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- IGA Finance
- RPTX Health Care
- Exchange
- IGA Nasdaq
- RPTX Nasdaq
- Market Cap
- IGA 147.6M
- RPTX 141.1M
- IPO Year
- IGA N/A
- RPTX 2020
- Fundamental
- Price
- IGA $9.25
- RPTX $1.32
- Analyst Decision
- IGA
- RPTX Strong Buy
- Analyst Count
- IGA 0
- RPTX 3
- Target Price
- IGA N/A
- RPTX $7.00
- AVG Volume (30 Days)
- IGA 42.3K
- RPTX 709.5K
- Earning Date
- IGA 01-01-0001
- RPTX 11-07-2024
- Dividend Yield
- IGA 8.93%
- RPTX N/A
- EPS Growth
- IGA N/A
- RPTX N/A
- EPS
- IGA N/A
- RPTX N/A
- Revenue
- IGA N/A
- RPTX $66,524,000.00
- Revenue This Year
- IGA N/A
- RPTX $13.22
- Revenue Next Year
- IGA N/A
- RPTX N/A
- P/E Ratio
- IGA N/A
- RPTX N/A
- Revenue Growth
- IGA N/A
- RPTX 18.19
- 52 Week Low
- IGA $7.77
- RPTX $1.23
- 52 Week High
- IGA $8.88
- RPTX $8.49
- Technical
- Relative Strength Index (RSI)
- IGA 36.32
- RPTX 30.27
- Support Level
- IGA $9.41
- RPTX $1.23
- Resistance Level
- IGA $9.45
- RPTX $4.07
- Average True Range (ATR)
- IGA 0.14
- RPTX 0.34
- MACD
- IGA -0.05
- RPTX -0.20
- Stochastic Oscillator
- IGA 26.47
- RPTX 3.34
About IGA Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest
Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategy.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.